Antibiotic therapy of pneumonia in the obese patient: dosing and delivery

作者:Al Dorzi Hasan M; Al Harbi Shmylan A; Arabi Yaseen M*
来源:Current Opinion in Infectious Diseases, 2014, 27(2): 165-173.
DOI:10.1097/QCO.0000000000000045

摘要

Purpose of reviewObesity has been shown to be associated with antibiotic underdosing and treatment failure. This article reviews the recent literature on antibiotic dosing in obese patients with pneumonia.Recent findingsObesity is associated with several alterations in antibiotic pharmacokinetics and pharmacodynamics, including increases in the antibiotic volume of distribution and clearance. These alterations necessitate changes in the dosing of certain antibiotics. However, data on antibiotic dosing for pneumonia in obese patients are limited and come mainly from observational studies. Additionally, dosing recommendations are often extrapolated from healthy obese volunteers and from the studies of antibiotics given for other indications.SummaryRecognizing obesity-related pharmacokinetic and pharmacodynamic alterations is important in treating obese patients with pneumonia. Studies that evaluate such alterations and assess the impact of antibiotic dosing and delivery on the clinical outcomes of this patient population are needed.

  • 出版日期2014-4